BDR Pharma has agreed to acquire a controlling interest in Acme's oral solid formulations business from shareholders led by PAG, strengthening its capabilities in specialist formulations while leaving Acme's sterile injectables operation outside the transaction.

CordenPharma is investing €80 million to expand aseptic fill-finish operations at its Caponago site in Italy, increasing projected sterile injectable capacity to up to 500 million units annually.